大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/12 | 2,412 | 2,419 | 2,343 | 2,359 | -53 | -2.2% | 642,800 |
2020/08/11 | 2,425 | 2,441 | 2,282 | 2,412 | -2 | -0.1% | 597,100 |
2020/08/07 | 2,466 | 2,496 | 2,390 | 2,414 | -70 | -2.8% | 586,200 |
2020/08/06 | 2,400 | 2,493 | 2,395 | 2,484 | +74 | +3.1% | 709,400 |
2020/08/05 | 2,386 | 2,417 | 2,358 | 2,410 | +33 | +1.4% | 402,300 |
2020/08/04 | 2,376 | 2,414 | 2,351 | 2,377 | +30 | +1.3% | 582,100 |
2020/08/03 | 2,340 | 2,380 | 2,301 | 2,347 | +43 | +1.9% | 513,700 |
2020/07/31 | 2,280 | 2,395 | 2,280 | 2,304 | +18 | +0.8% | 762,800 |
2020/07/30 | 2,209 | 2,298 | 2,186 | 2,286 | +77 | +3.5% | 586,900 |
2020/07/29 | 2,204 | 2,255 | 2,161 | 2,209 | -7 | -0.3% | 348,000 |
2020/07/28 | 2,179 | 2,242 | 2,179 | 2,216 | +46 | +2.1% | 404,900 |
2020/07/27 | 2,152 | 2,183 | 2,111 | 2,170 | -12 | -0.5% | 453,000 |
2020/07/22 | 2,191 | 2,199 | 2,144 | 2,182 | ±0 | ±0% | 372,600 |
2020/07/21 | 2,151 | 2,182 | 2,147 | 2,182 | +32 | +1.5% | 267,900 |
2020/07/20 | 2,136 | 2,208 | 2,131 | 2,150 | -12 | -0.6% | 367,700 |
2020/07/17 | 2,205 | 2,214 | 2,131 | 2,162 | -46 | -2.1% | 611,700 |
2020/07/16 | 2,249 | 2,267 | 2,202 | 2,208 | -27 | -1.2% | 430,400 |
2020/07/15 | 2,256 | 2,270 | 2,192 | 2,235 | -18 | -0.8% | 395,500 |
2020/07/14 | 2,270 | 2,354 | 2,230 | 2,253 | -31 | -1.4% | 651,700 |
2020/07/13 | 2,237 | 2,297 | 2,175 | 2,284 | +82 | +3.7% | 613,000 |
2020/07/10 | 2,221 | 2,284 | 2,199 | 2,202 | -4 | -0.2% | 508,900 |
2020/07/09 | 2,266 | 2,287 | 2,185 | 2,206 | -60 | -2.6% | 681,400 |
2020/07/08 | 2,320 | 2,363 | 2,250 | 2,266 | -58 | -2.5% | 622,900 |
2020/07/07 | 2,371 | 2,403 | 2,285 | 2,324 | -75 | -3.1% | 688,000 |
2020/07/06 | 2,478 | 2,478 | 2,390 | 2,399 | -78 | -3.1% | 736,700 |
2020/07/03 | 2,450 | 2,484 | 2,390 | 2,477 | +34 | +1.4% | 408,100 |
2020/07/02 | 2,529 | 2,554 | 2,358 | 2,443 | -84 | -3.3% | 942,200 |
2020/07/01 | 2,624 | 2,637 | 2,513 | 2,527 | -73 | -2.8% | 490,700 |
2020/06/30 | 2,632 | 2,643 | 2,536 | 2,600 | -26 | -1% | 780,100 |
2020/06/29 | 2,594 | 2,681 | 2,576 | 2,626 | +23 | +0.9% | 829,500 |
2020/06/26 | 2,608 | 2,619 | 2,535 | 2,603 | -3 | -0.1% | 552,000 |
2020/06/25 | 2,590 | 2,653 | 2,570 | 2,606 | -2 | -0.1% | 664,600 |
2020/06/24 | 2,500 | 2,630 | 2,487 | 2,608 | +91 | +3.6% | 873,200 |
2020/06/23 | 2,546 | 2,546 | 2,456 | 2,517 | -4 | -0.2% | 477,800 |
2020/06/22 | 2,458 | 2,552 | 2,450 | 2,521 | +59 | +2.4% | 722,300 |
2020/06/19 | 2,487 | 2,508 | 2,426 | 2,462 | -16 | -0.6% | 613,300 |
2020/06/18 | 2,465 | 2,520 | 2,433 | 2,478 | +15 | +0.6% | 603,700 |
2020/06/17 | 2,379 | 2,505 | 2,352 | 2,463 | +86 | +3.6% | 1,241,300 |
2020/06/16 | 2,222 | 2,385 | 2,211 | 2,377 | +182 | +8.3% | 1,075,500 |
2020/06/15 | 2,250 | 2,276 | 2,193 | 2,195 | -55 | -2.4% | 643,700 |
2020/06/12 | 2,130 | 2,254 | 2,120 | 2,250 | +58 | +2.6% | 770,200 |
2020/06/11 | 2,265 | 2,277 | 2,172 | 2,192 | -40 | -1.8% | 487,900 |
2020/06/10 | 2,220 | 2,264 | 2,215 | 2,232 | -6 | -0.3% | 497,900 |
2020/06/09 | 2,185 | 2,249 | 2,120 | 2,238 | +31 | +1.4% | 790,400 |
2020/06/08 | 2,291 | 2,297 | 2,199 | 2,207 | -107 | -4.6% | 1,039,700 |
2020/06/05 | 2,354 | 2,366 | 2,271 | 2,314 | -61 | -2.6% | 809,800 |
2020/06/04 | 2,320 | 2,378 | 2,290 | 2,375 | +21 | +0.9% | 762,700 |
2020/06/03 | 2,288 | 2,354 | 2,283 | 2,354 | +96 | +4.3% | 1,129,200 |
2020/06/02 | 2,191 | 2,284 | 2,175 | 2,258 | +36 | +1.6% | 1,125,300 |
2020/06/01 | 2,149 | 2,256 | 2,114 | 2,222 | -25 | -1.1% | 2,057,000 |
1051~
1100
件表示中 / 3839件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム